archive-com.com » COM » A » AGENDIA.COM

Total: 235

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Bastiaan van der Baan | Agendia
    is Vice President of Clinical Affairs at Agendia and joined the Company shortly after its founding in 2003 Bas holds a degree in molecular sciences and has over 15 years of healthcare experience in commercial roles and has held positions at Unilever and other biotechnology start ups We d Love To Hear From You Name Email Questions Comments Concerns Questions Comments Concerns Comments This field is for validation purposes and

    Original URL path: http://www.agendia.com/management/bastiaan-van-der-baan/ (2016-05-01)
    Open archived version from archive


  • Annuska Glas, Ph.D | Agendia
    had a pivotal role in the development of MammaPrint working as a molecular biologist at the Netherlands Cancer Institute NKI with Dr Laura van t Veer Prior to NKI Annuska was a research associate at the Benaroya Research Institute Seattle WA for 8 years and received her Ph D degree in Molecular Immunology in 2000 We d Love To Hear From You Name Email Questions Comments Concerns Questions Comments Concerns

    Original URL path: http://www.agendia.com/management/annuska-glas-ph-d/ (2016-05-01)
    Open archived version from archive

  • Tammy Marcotte | Agendia
    health and breast cancer First with Johnson and Johnson Ethicon Endosurgery Biopsys Breast Health Division Paving the way for vacuum assisted core biopsy as the standard of care in breast biopsy and then with Hologic Proxima Therapeutics Cytyc which focused on innovative radiation treatment for early stage breast cancer Having experience in both commercial and clinical roles Tammy brings a unique perspective to the US sales force with a patient

    Original URL path: http://www.agendia.com/management/tammy-marcotte/ (2016-05-01)
    Open archived version from archive

  • Dr. Franklin Libenson, MD | Agendia
    Market Access Dr Libenson graduated from Anahuac University in Mexico City and completed his Medical Internship at Jackson Memorial Hospital in Miami FL He obtained his MPH from Harvard University with a concentration in Healthcare management Dr Libenson joined Agendia in 2010 and has over 15 years commercial and operational experience in the healthcare industry We d Love To Hear From You Name Email Questions Comments Concerns Questions Comments Concerns

    Original URL path: http://www.agendia.com/management/franklin-libenson-md/ (2016-05-01)
    Open archived version from archive

  • Annette Meijering | Agendia
    of Human Resources Organizational Development Annette Meijering is Vice President of Human Resources Organizational Development and joined the Company shortly after its founding in 2003 Annette holds a Master s degree from the University of Amsterdam We d Love To Hear From You Name Email Questions Comments Concerns Questions Comments Concerns Comments This field is for validation purposes and should be left unchanged Resources Online Ordering Publications Studies Physician Education

    Original URL path: http://www.agendia.com/management/annette-meijering/ (2016-05-01)
    Open archived version from archive

  • 2015 Event Calendar | Agendia
    Vienna Austria Dec 8 12 SABCS 2015 San Antonio Breast Cancer Symposium San Antonio TX Past Events Date Event May 29 June 2 2015 ASCO American Society of Clinical Oncology Chicago IL Apr 29 May 3 2015 ASBS American Society of Breast Surgeons 16th Annual Meeting Orlando FL Mar 25 28 2015 SSO Society of Surgical Oncology Cancer Symposium Houston TX Mar 18 21 2015 14th St Gallen Breast Cancer Conference Vienna Austria Mar 14 18 2015 NCBC National Conference on Breast Cancer 25th Anniversary Las Vegas NV Mar 12 14 2015 20th NCCN National Comprehensive Cancer Network Conference Hollywood FL Feb 26 Mar 1 2015 32nd Annual Miami Breast Cancer Conference Miami Beach FL Dec 8 12 2014 SABCS SAN ANTONIO BREAST CANCER SYMPOSIUM San Antonio TX Oct 16 19 2014 SIS World Congress on Breast Healthcare Orlando FL Oct 8 11 2014 ACCC 31st Annual National Oncology Meeting San Diego CA Sep 26 30 2014 ESMO European Society for Medical Oncology Madrid Spain Sep 7 9 2014 CAP College of American Pathologists Chicago IL Sep 4 6 2014 ASCO Breast Cancer Symposium San Francisco CA We d Love To Hear From You Name Email Questions Comments Concerns Questions

    Original URL path: http://www.agendia.com/agendia-event-calendar-for-2014/ (2016-05-01)
    Open archived version from archive

  • 2016 | Agendia
    excess of 94 percent whether randomized to receive adjuvant chemotherapy or not MammaPrint could change clinical practice by substantially de escalating the Continued MINDACT results will be presented during the AACR Annual Meeting 2016 April 1 2016 EORTC European Organisation for Research and Treatment of Cancer BIG Breast International Group and Agendia are pleased to announce that the Primary analysis of the EORTC 10041 BIG 3 04 MINDACT study a Continued Agendia to Highlight New MammaPrint Data at the 2016 European Breast Cancer Conference as a Prelude to Upcoming MINDACT Trial Findings March 8 2016 Company will also host a lunch symposium on genomic assays and their clinical relevance at the 2016 Miami Breast Cancer Conference MBCC IRVINE CA and AMSTERDAM Agendia Inc a world leader in personalized medicine and molecular cancer diagnostics announced Continued Agendia Statement in Response to Recent ASCO Guidelines on Biomarker Assay Use in Adjuvant Breast Cancer Care February 11 2016 Agendia is disappointed with the recent update to the American Society of Clinical Oncology ASCO Clinical Practice Guidelines and with the decision to move forward without key research that we feel would have a material effect on the guidelines We Continued Categories Abstract Poster 18

    Original URL path: http://www.agendia.com/2016/ (2016-05-01)
    Open archived version from archive

  • 2015 | Agendia
    leader Mark R Straley as Chief Executive Officer He succeeds Jan Egberts M D who took Continued NCCN Breast Cancer Guidelines Acknowledge MammaPrint s Ability to Predict Prognosis July 28 2015 Respected Panel Cites RASTER the Only Published Prospective Outcome Data of Its Kind Which Demonstrates MammaPrint s Ability to Identify Those Patients Who May Safely Forego Chemotherapy IRVINE CA and AMSTERDAM THE NETHERLANDS Agendia a global molecular diagnostics company that Continued DNA repair deficiency biomarkers identify HR HER2 breast cancer patients who may benefit from veliparib carboplatin results from the I SPY 2 TRIAL Author s L van t Veer L Esserman A Sanil A Glas T Severson S Linn L Brown Swigart G Hirst I SPY 2 TRIAL Investigators O Olapade H Rugo D Berry D M Wolf and C Yau June 1 2015 Background In I SPY 2 HER2 patients were adaptively randomized to receive standard chemotherapy or the PARP inhibitor veliparib with carboplatin V C and chemotherapy V C graduated in the triple negative TN subtype and we have previously shown that DNA repair deficiency signatures PARPi 7 and BRCAness Continued Functional Subtyping with BluePrint 80 gene profile identifies distinct triple positive subtypes with and without trastuzumab pertuzumab chemo sensitivity Author s Pat Whitworth Peter Beitsch Paul Baron Michael C Rotkis James V Pellicane Mary Murray Carrie L Dul Angela M Mislowsky Charles H Nash Paul D Richards Laura A Lee Lisette Stork Sloots Femke de Snoo Sarah Untch Mark Gittleman Stephanie Akbari Jennifer Beatty June 1 2015 Background and Aim Classification into molecular subtypes is important for the selection of therapy for patients with breast cancer Previous analyses demonstrated that breast cancer subtypes have distinct clinical outcome Glück BCRT 2013 The aim of the prospective NBRST study is to compare a Continued Agendia Announces Recommendation

    Original URL path: http://www.agendia.com/2015/ (2016-05-01)
    Open archived version from archive



  •